A detailed history of Annapolis Financial Services, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Annapolis Financial Services, LLC holds 39 shares of MRNA stock, worth $1,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Previous 39 -0.0%
Holding current value
$1,437
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 20, 2023

SELL
$118.38 - $210.04 $947 - $1,680
-8 Reduced 17.02%
39 $0
Q1 2022

Apr 29, 2022

BUY
$126.46 - $235.05 $4,931 - $9,166
39 Added 487.5%
47 $8,000
Q2 2021

Aug 04, 2021

SELL
$129.91 - $234.98 $2,078 - $3,759
-16 Reduced 66.67%
8 $2,000
Q1 2021

May 06, 2021

BUY
$109.18 - $185.98 $2,620 - $4,463
24 New
24 $3,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Annapolis Financial Services, LLC Portfolio

Follow Annapolis Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annapolis Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annapolis Financial Services, LLC with notifications on news.